Rutgers will provide antibody testing to help determine the incidence and long-term effects of COVID-19 in children as part of an initiative by the National Institutes of Health. The serological testing, which detects the presence of antibodies directed against proteins produced by SARS-CoV-2 – the virus causing COVID-19 – will be performed in the laboratory of Maria Laura Gennaro, a professor of medicine and epidemiology at the Public Health Research Institute at Rutgers New Jersey Medical School and a core faculty member of Rutgers Global Health Institute. “We will screen for anti-SARS-CoV-2 antibodies sera from over 30,000 subjects among children and their caretakers enrolled in the pediatric RECOVER cohort,” said Natalie Bruiners, an assistant professor at Rutgers New Jersey Medical School who will supervise the project. To read the full story.